AJ

Aimee Jackson

MT Miragen Therapeutics: 5 patents #5 of 14Top 40%
Merck: 5 patents #2,116 of 9,382Top 25%
📍 Boulder, CO: #701 of 5,018 inventorsTop 15%
🗺 Colorado: #4,613 of 40,980 inventorsTop 15%
Overall (All Time): #507,305 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
10316318 Oligonucleotide compositions and uses thereof David Rodman, Anita Seto, Christina Dalby, Xuan BEATTY 2019-06-11
10280422 MiR-92 inhibitors and uses thereof Christina Dalby, Corrie Lynn Gallant-Behm, Kathryn Hutnick, Anita Seto 2019-05-07
9994852 Oligonucleotide compositions and uses thereof David Rodman, Anita Seto, Christina Dalby, Xuan BEATTY 2018-06-12
9885042 miR-92 inhibitors and uses thereof Christina Dalby, Corrie Lynn Gallant-Behm, Kathryn Hutnick, Anita Seto 2018-02-06
9771585 miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL) David Rodman, Anita Seto, Christina Dalby, Xuan BEATTY 2017-09-26
8609830 Methods and compositions for RNA interference Steven Bartz, Julja Burchard, Janell Schelter, Peter S. Linsley 2013-12-17
8457902 Method for selecting SIRNAs from a plurality of SIRNAs for gene silencing Steven Bartz, Julja Burchard, Peter S. Linsley, Ge Wei, Guy L. Cavet 2013-06-04
8399248 Methods of using MIR34 as a biomarker for TP53 functional status Michele A. Cleary, Peter S. Linsley, Julja Burchard, Lee Lim, Jill F. Magnus +4 more 2013-03-19
8378088 Compositions comprising MIR34 therapeutic agents for treating cancer Michele A. Cleary, Peter S. Linsley, Julja Burchard, Lee Lim, Jill F. Magnus 2013-02-19
7962316 Method of designing siRNAs for gene silencing Steven Bartz, Julja Burchard, Peter S. Linsley, Wei Ge, Guy L. Cavet 2011-06-14